bovin
group
rotaviru
rva
consid
major
caus
diarrhea
intens
rear
neonat
calv
chicken
egg
yolk
antibodi
igi
effici
protect
neonat
calv
rva
diarrhea
howev
valu
intervent
calv
diarrhea
appear
unclear
aim
present
studi
evalu
applic
rvaspecif
igi
passiv
treatment
case
experiment
group
rvaspecif
igi
treatment
ab
treatment
colostrum
depriv
ab
treatment
igi
treatment
significantli
reduc
viru
shed
diarrhea
durat
sever
compar
calv
howev
caus
partial
suppress
system
ab
respons
rva
could
associ
less
sever
diarrhea
oral
treatment
igi
day
associ
significantli
higher
antibodi
secret
cell
respons
calv
compar
group
anim
numer
epidemiolog
studi
shown
group
rotavirus
rva
frequent
caus
sever
gastroenter
young
children
anim
est
kapikian
dhama
et
al
martella
et
al
electron
microcopi
use
detect
viru
associ
neonat
calf
diarrhea
mebu
et
al
multipl
etiolog
agent
respons
neonat
diarrhea
calv
includ
rva
coronaviru
escherichia
coli
salmonella
speci
clostridium
perfringen
cryptosporidium
coccidia
bellinzoni
et
al
holland
bendali
et
al
svennerholm
steel
among
agent
bovin
rva
consid
major
caus
enter
diarrhea
artifici
rear
calv
caus
import
econom
loss
relat
death
treatment
cost
reduct
weight
gain
affect
anim
malik
et
al
martella
et
al
diarrheal
diseas
sever
enhanc
sever
factor
includ
herd
manag
environ
host
nutrit
immunolog
statu
saif
smith
bendali
et
al
diseas
usual
occur
calv
sever
decreas
age
increas
incub
period
short
h
diarrhea
selflimit
within
day
unless
secondari
bacteri
infect
occur
svennerholm
steel
dhama
et
al
bovin
rva
strain
genet
antigen
heterogen
genet
classif
base
gene
code
two
outer
capsid
protein
determin
g
p
type
respect
singl
preval
genotyp
combin
among
bovin
rva
strain
although
spatiotempor
herd
farm
type
cattl
dairi
differ
rva
strain
distribut
observ
worldwid
garaicoechea
et
al
badaracco
et
al
papp
et
al
bovin
rva
ubiquit
infect
enterocyt
tip
villi
within
small
intestin
neonat
calv
multifactori
mechan
infect
disrupt
effici
absorpt
enterocyt
potenti
activ
enter
nervou
system
induc
malabsorpt
secretori
diarrhea
bridger
malik
et
al
lundgren
svensson
dhama
et
al
martella
et
al
viru
replic
quickli
gener
high
yield
virion
complet
transmiss
cycl
host
immun
mechan
interven
est
kapikian
affect
calv
manifest
sever
diarrhea
dehydr
hyperthermia
anorexia
lethargi
bellinzoni
et
al
holland
bendali
et
al
dhama
et
al
good
manag
hygien
practic
help
reduc
sever
rva
diarrhea
farm
anim
antibiot
use
control
secondari
bacteri
infect
fluid
electrolyt
therapi
help
restor
fluid
reserv
minim
calf
mortal
holland
svennerholm
steel
gastrointestin
pathogen
local
gutassoci
lymphoid
tissu
galt
respons
critic
viru
clearanc
prevent
rva
reinfect
rvaspecif
passiv
matern
antibodi
ab
acquir
colostrum
intak
system
absorb
resecret
gut
well
ab
present
matern
milk
act
local
key
factor
protect
neonat
stott
fellah
besser
et
al
saif
fernandez
barrandeguy
et
al
fernandez
et
al
hodgin
et
al
kohara
tsunemitsu
et
al
dam
immun
rvainactiv
vaccin
last
third
pregnanc
day
prior
parturit
enhanc
matern
ab
level
serum
promot
higher
concentr
immunoglobulin
colostrum
holland
saif
fernandez
barrandeguy
et
al
svennerholm
steel
although
ab
present
colostrum
enter
circul
protect
enter
diseas
primarili
depend
presenc
rvaspecif
ab
calv
intestin
lumen
indic
protect
could
achiev
presenc
passiv
ab
gut
lumen
combin
rapid
activ
antibodi
secret
cell
asc
respons
intestin
lamina
propria
saif
fernandez
fernandez
et
al
regard
passiv
immun
protect
calv
receiv
pool
colostrum
vaccin
dam
prior
gut
closur
within
h
birth
protect
sever
diarrhea
et
al
howev
rvaspecif
ab
colostrum
declin
calv
seem
insuffici
high
challeng
dose
viru
hand
supplement
milk
diet
immun
colostrum
significantli
reduc
diarrhea
delay
viral
shed
onset
kohara
tsunemitsu
et
al
howev
product
immun
milk
base
colostrum
supplement
industri
scalabl
altern
highlight
need
anoth
sourc
larg
amount
ab
immunotherapeut
purpos
costeffici
way
recent
chicken
attract
consider
attent
altern
sourc
antibodi
igi
deposit
egg
yolk
larg
quantiti
make
chicken
ideal
sourc
specif
polyclon
antibodi
touchett
et
al
kovacsnolan
mine
sever
report
chicken
egg
yolk
ab
igi
highli
effect
protect
neonat
calv
bovin
rva
diarrhea
ikemori
et
al
kuroki
et
al
kuroki
et
al
group
describ
prophylact
provis
hyperimmun
crude
fluid
egg
yolk
newborn
calv
first
consecut
day
life
significantli
reduc
sever
diarrhea
oral
inocul
virul
bovin
rva
treatment
also
prevent
rva
diarrhea
viru
shed
second
viru
challeng
seven
day
end
passiv
ab
treatment
observ
egg
yolk
treatment
promot
modulatori
effect
asc
respons
gut
induc
high
number
bovin
rvaspecif
iga
asc
vega
et
al
prophylact
treatment
could
advantag
dairi
herd
bovin
rva
major
epidemiolog
concern
still
oral
igybas
treatment
use
dairi
farm
rvaassoci
diarrhea
concern
less
sever
decreas
therapi
cost
littl
known
use
igi
ab
treatment
bovin
rva
viru
infect
alreadi
induc
diarrhea
control
environment
condit
aim
present
studi
determin
potenti
applic
spray
dri
egg
yolk
powder
enrich
bovin
rvaspecif
igi
ab
passiv
therapeut
treatment
appli
day
appear
diarrhea
neonat
calv
experiment
challeng
virul
bovin
rva
strain
potenti
powder
commerci
product
evalu
protocol
anim
manag
euthanasia
met
requir
institut
anim
care
committe
iacc
protocol
number
veterinari
colleg
univers
bueno
air
institut
committe
experiment
anim
use
manag
inta
protocol
number
calv
chicken
colostrum
feed
experiment
group
passiv
treatment
administr
fifteen
newborn
male
holstein
calv
acquir
dairi
farm
remov
dam
birth
prior
suckl
move
isol
facil
within
first
h
life
anim
hous
individu
isol
room
strict
manag
protocol
previous
describ
calv
randomli
assign
one
follow
feed
group
g
colostrum
c
milk
supplement
bovin
rvaspecif
egg
yolk
powder
final
elisa
igi
ab
titer
indiana
rva
strain
n
c
rva
ab
free
milk
n
colostrum
depriv
cd
rva
ab
free
milk
n
last
two
group
calv
consid
control
colostrum
depriv
calv
often
found
herd
anim
artifici
assist
mani
newborn
fail
fed
first
hour
life
calv
receiv
l
colostrum
pool
rva
nonvaccin
cow
seroposit
rva
due
natur
exposur
viru
field
within
first
h
life
prior
gut
closur
colostrum
viru
neutral
vn
ab
titer
indiana
bovin
rva
strain
genotyp
elisa
ab
titer
produc
previous
describ
vega
et
al
anim
circul
elisa
mean
ab
titer
indiana
bovin
rva
strain
serum
colostrum
intak
calv
receiv
colostrum
l
rva
ab
free
milk
time
point
remain
seroneg
bovin
rva
expect
milk
use
experi
commerci
steril
bovin
milk
human
consumpt
mastellon
hno
argentina
anim
oral
inocul
focu
form
unit
ffu
virul
bovin
rva
strain
indiana
strain
third
fourth
feed
postinocul
day
pid
viral
dose
previous
confirm
caus
diarrhea
viru
shed
inocul
cd
calv
viral
strain
one
preval
rva
strain
circul
newborn
calv
argentina
garaicoechea
et
al
badaracco
et
al
worldwid
midgley
et
al
papp
et
al
immedi
onset
diarrhea
calv
assign
igi
passiv
treatment
group
receiv
l
supplement
milk
twice
day
day
final
elisa
igi
ab
titer
bovin
rva
indiana
strain
time
calv
group
fed
milk
without
supplement
ab
calv
fed
commerci
rva
ab
free
milk
experi
calv
euthan
pid
studi
primari
ab
respons
bovin
rva
infect
calv
examin
daili
develop
diarrhea
viru
shed
virul
bovin
rva
inocul
rectal
temperatur
measur
experi
valu
consid
hyperthermia
estim
sever
diarrhea
fecal
consist
score
blindli
qualifi
technician
follow
normal
pasti
semiliquid
liquid
consid
score
equal
greater
diarrhea
area
fecal
score
curv
auc
calf
determin
averag
auc
diarrhea
calcul
group
prior
virul
bovin
rva
inocul
fecal
sampl
collect
daili
assess
viru
shed
serum
sampl
collect
colostrum
feed
within
h
birth
bovin
rva
inocul
approxim
h
birth
weekli
pid
serum
ab
bovin
rva
indiana
strain
assay
elisa
vn
test
presenc
coproantibodi
coproab
also
assess
elisa
peripher
blood
lymphocyt
pbl
sampl
pid
weekli
assess
asc
respons
elispot
assay
pid
anim
euthan
number
bovin
rva
asc
quantifi
elispot
follow
gutassoci
lymphoid
tissu
galt
duodenum
jejunum
ileum
lamina
propria
lp
jejunum
ileum
peyer
patch
pp
jejunum
cecal
mesenter
lymph
node
mln
system
lymphoid
tissu
spleen
pbl
larg
lic
small
sic
intestin
content
calv
collect
necropsi
bovin
rva
specif
ab
detect
elisa
virul
bovin
rva
correspond
indiana
strain
genotyp
inoculum
use
calf
experiment
infect
consist
intestin
content
cd
calf
oral
inocul
fecal
suspens
contain
rva
strain
previous
describ
et
al
cellcultureadapt
indiana
rva
strain
also
propag
monkey
kidney
cell
use
elispot
elisa
vn
assay
lohmann
brown
classic
lay
hen
immun
intramuscularli
breast
live
attenu
indiana
rva
strain
genotyp
contain
ffuml
previous
describ
vega
et
al
collect
egg
immun
hen
group
weekli
yolk
dilut
distil
water
ratio
store
rva
igi
ab
titer
pool
determin
indiana
rva
elisa
vn
assay
pool
rva
igi
ab
titer
spraydri
flexpump
galaxi
sa
argentina
obtain
egg
yolk
powder
powder
dilut
rva
ab
free
milk
mgml
igi
elisa
ab
titer
indiana
rva
strain
total
g
egg
yolk
powder
dilut
l
rva
ab
free
milk
reach
elisa
igi
ab
titer
supplement
milk
vn
titer
indiana
rva
strain
product
qualiti
stabil
evalu
everi
period
briefli
sampl
kept
room
temperatur
rel
humid
rh
room
rh
rh
rh
similar
trialuminum
packag
gener
data
stabil
normal
acceler
condit
respect
day
powder
product
packag
open
sampl
prepar
rva
ab
free
milk
note
igi
elisa
ab
titer
indiana
rva
strain
determin
immedi
time
point
egg
yolk
powder
sent
privat
laboratori
determin
physicochem
composit
microbiolog
statu
product
viru
shed
detect
fecal
sampl
use
antigen
captur
elisa
previous
describ
cornaglia
et
al
genotyp
molecular
ident
rva
confirm
nest
rtpcr
follow
dna
sequenc
analysi
describ
elsewher
garaicoechea
et
al
badaracco
et
al
infecti
viru
titer
assess
ccif
assay
et
al
fluoresc
foci
visual
use
fitclabel
hyperimmun
bovin
polyclon
antiserum
specif
indiana
bovin
rva
strain
genotyp
prepar
inta
fluoresc
fociform
cell
count
use
fluoresc
microscop
titer
express
number
fluoresc
focu
form
unit
per
ml
ffuml
auc
calf
first
determin
averag
auc
viru
shed
calcul
group
igm
iga
ab
titer
indiana
rva
strain
determin
colostrum
calf
sera
fece
lic
sic
specif
ab
detect
indirect
elisa
specif
igm
iga
ab
measur
captur
elisa
use
reagent
protocol
previous
describ
et
al
vega
et
al
igi
ab
titer
indiana
rva
strain
determin
crude
egg
yolk
pool
calf
hen
sera
calf
fece
supplement
milk
indirect
elisa
previous
describ
vega
et
al
viru
neutral
ab
titer
indiana
rva
strain
colostrum
pool
egg
yolk
pool
supplement
milk
calf
sera
determin
ffn
test
previous
describ
vega
et
al
vn
titer
express
reciproc
highest
sampl
dilut
result
reduct
number
fluoresc
foci
et
al
approxim
cm
tissu
sampl
duodenum
jejunum
ileum
lamina
propria
collect
discret
peyer
patch
pp
n
anim
identifi
differ
point
along
mucos
surfac
jejunum
collect
individu
segment
intestin
correspond
cm
portion
distal
ileum
continu
pp
also
obtain
mesenter
lymph
node
mln
correspond
jejunum
ileocec
region
collect
process
separ
intestin
tissu
process
previous
describ
vega
et
al
elispot
assay
quantif
antirva
igm
iga
asc
conduct
evalu
effector
bcell
respons
calv
pid
sever
system
gut
associ
galt
lymphoid
tissu
previous
describ
vega
et
al
fisher
exact
test
use
compar
proport
calv
diarrhea
viru
shed
among
group
kruskalw
rank
sum
nonparametr
test
use
compar
day
onset
durat
diarrhea
viru
shed
cumul
diarrhea
score
auc
cumul
titer
viru
shed
day
elev
rectal
temperatur
among
group
vn
isotypespecif
ab
titer
log
transform
prior
statist
analysi
differ
ab
titer
among
group
evalu
gener
analysi
varianc
anova
follow
dgc
di
rienzo
casanov
multipl
comparison
test
repeat
measur
throughout
time
neg
sampl
dilut
assign
arbitrari
ab
titer
calcul
geometr
mean
titer
gmt
pid
asc
number
compar
among
group
use
kruskalw
rank
sum
test
statist
signific
assess
p
b
comparison
statist
analys
conduct
use
argentina
statist
softwar
passiv
treatment
egg
yolk
powder
contain
bovin
rva
igi
ab
significantli
reduc
diarrhea
durat
sever
compar
colostrum
depriv
calv
experi
newborn
calv
assign
experiment
group
oral
inocul
virul
bovin
rva
indiana
strain
genotyp
h
life
onset
diarrhea
viru
inocul
statist
similar
group
calv
day
day
day
agreement
bovin
rva
infecti
viral
particl
detect
fece
anim
day
diarrhea
appear
result
diarrhea
viru
shed
detail
fig
follow
experiment
design
calv
assign
receiv
rva
igi
ab
treatment
within
h
sinc
develop
diarrhea
seven
consecut
day
diarrhea
group
termin
averag
day
begin
passiv
treatment
rang
day
durat
significantli
shorter
one
regist
cd
calv
day
anim
fed
colostrum
follow
rva
ab
free
milk
develop
rvaassoci
diarrhea
intermedi
durat
averag
day
interestingli
viru
shed
durat
significantli
shorter
calv
averag
day
anim
averag
day
calv
show
intermedi
durat
day
fig
viru
shed
diarrhea
durat
coproab
titer
fece
experiment
group
calv
calv
fed
two
liter
commerci
bovin
milk
supplement
g
egg
yolk
powder
contain
indiana
rva
strainspecif
igi
ab
twice
day
day
diarrhea
onset
calv
fed
rva
ab
free
milk
without
supplement
continu
line
repres
averag
elisa
ab
titer
isotypespecif
bovin
coproab
bovin
indiana
rva
strain
detect
fece
dash
line
repres
averag
elisa
igi
ab
titer
indiana
rva
strain
column
repres
averag
daili
profil
viru
shed
experiment
calv
express
ffuml
horizont
bar
indic
mean
diarrhea
durat
tabl
includ
graph
indic
diarrhea
durat
defin
number
day
fecal
score
fece
consist
score
daili
normal
pasti
semiliquid
liquid
mean
column
differ
superscript
upper
case
letter
differ
significantli
kruskalw
rank
sum
test
p
b
determin
elisa
ccif
number
day
bovin
rvaassoci
hyperthermia
consid
day
bodi
temperatur
c
colostrumcd
colostrum
depriv
auc
area
diarrheaviru
shed
curv
pid
post
inocul
day
vs
viru
shed
lic
larg
intestin
content
sic
small
intestin
content
averag
howev
area
curv
viru
shed
auc
significantli
differ
experiment
group
calv
sever
rvaassoci
diarrhea
consid
averag
auc
diarrhea
score
group
calv
also
significantli
lower
rva
igi
ab
treat
calv
either
group
anim
furthermor
signific
reduct
number
day
rvaassoci
hyperthermia
calv
day
averag
compar
anim
control
group
day
day
import
mention
anim
receiv
passiv
rvaspecif
igi
ab
treatment
show
clinic
sign
bovin
rva
infect
like
anorexia
dehydr
depress
person
observ
data
shown
evid
calv
special
calv
clear
viral
infect
passiv
treatment
igi
ab
infecti
viru
detect
experi
fig
shown
igi
ab
indiana
rva
strain
passiv
treatment
detect
elisa
fece
calv
fig
elisa
igi
ab
titer
rva
vari
daili
could
associ
viral
replic
shed
especi
increas
titer
observ
rvainfect
clear
around
pid
final
igi
ab
disappear
one
two
day
end
passiv
treatment
fig
passiv
activ
protect
rva
diarrhea
desir
outcom
treatment
vaccin
achiev
even
continu
viral
shed
detect
fece
moreov
asymptomat
infect
allow
develop
activ
immun
prevent
subsequ
natur
rva
infect
howev
also
previous
demonstr
oral
passiv
treatment
base
egg
yolk
caus
strong
posit
modul
local
humor
immun
respons
special
antibodi
secret
cell
respons
intestin
mucosa
vega
et
al
character
calv
immun
respons
rva
conduct
studi
local
ab
respons
bovin
rva
fece
isotypespecif
elisa
result
obtain
also
depict
fig
togeth
viru
shed
diarrhea
durat
cd
calv
bovin
rvaspecif
igm
iga
ab
peak
pid
respect
fig
similar
pattern
observ
calv
c
rva
ab
free
milk
iga
ab
peak
pid
igm
ab
show
low
titer
pid
anim
c
bovin
rva
igi
ab
milk
also
evid
fig
ab
bovin
rva
present
around
pid
fece
calv
receiv
colostrum
absent
calv
howev
pid
anim
cd
rva
ab
free
milk
show
detect
elisa
titer
indiana
rva
strain
specif
fece
fig
similarli
pattern
describ
serum
fig
end
experi
calv
present
well
iga
ab
indiana
rva
strain
fece
although
signific
differ
observ
coproab
titer
bovin
rva
calv
show
trend
toward
lower
rva
ab
titer
anim
fig
pid
anim
euthan
content
larg
lic
small
sic
intestin
section
collect
bovin
ab
indiana
rva
strain
also
detect
elisa
assay
see
fig
iga
ab
predomin
especi
high
bovin
rvaspecif
elisa
ab
titer
cd
rva
ab
free
milk
compar
iga
ab
titer
sic
calv
significantli
lower
calv
show
intermedi
respons
ab
titer
determin
statist
similar
among
group
calv
accord
scenario
observ
fece
end
experi
fig
profil
isotyp
bovin
ab
indiana
rva
strain
serum
depict
fig
pid
previou
experiment
virul
bovin
rva
inocul
ab
bovin
rva
present
anim
receiv
colostrum
birth
indic
transfer
gut
bloodstream
associ
presenc
vn
activ
bovin
rva
experiment
time
point
calv
ab
titer
indiana
rva
strain
remain
constant
serum
sampl
anim
experi
group
calv
virul
bovin
rva
inocul
possibl
discrimin
detect
serum
deriv
colostrum
intak
repres
activ
product
neonat
fig
expect
ab
detect
serum
sampl
calv
cd
anim
pid
elisa
ab
titer
bovin
rva
increas
progress
pid
pid
statist
similar
anim
experiment
group
pid
end
experi
pid
pid
main
isotyp
detect
serum
iga
igm
still
present
lower
titer
experiment
group
fig
expect
primari
immun
respons
rva
igm
isotyp
detect
elisa
serum
pid
calv
experiment
time
point
igm
ab
titer
indiana
rva
strain
significantli
higher
show
intermedi
respons
fig
igm
titer
peak
around
pid
decreas
reach
statist
similar
titer
pid
group
hand
iga
ab
indiana
rva
strain
also
detect
pid
experiment
group
calv
peak
around
pid
calv
statist
lower
elisa
iga
ab
titer
bovin
rva
pid
anim
titer
intermedi
vn
ab
remain
constant
throughout
experi
clear
increment
begin
experi
pid
experiment
time
point
vn
titer
statist
similar
group
interestingli
anim
show
decreas
ab
titer
indiana
rva
strain
pid
fig
end
experi
pid
differ
tissu
collect
determin
number
isotyp
indiana
rva
strainspecif
asc
elispot
assay
result
obtain
system
tissu
blood
spleen
jejun
mln
ileocec
mln
depict
fig
asc
respons
galt
shown
fig
pid
anim
asc
indiana
rva
strain
studi
tissu
gener
number
asc
system
tissu
calv
c
rva
igi
ab
lower
group
calv
particular
number
bovin
rvaspecif
igm
asc
respons
spleen
calv
c
rva
igi
ab
significantli
less
one
anim
mln
jejun
ileocec
region
statist
differ
observ
asc
bovin
indiana
rva
strain
colostrum
depriv
calv
higher
number
anim
interestingli
calv
c
rva
ab
free
predomin
asc
isotyp
detect
pid
igm
follow
iga
system
tissu
studi
contrast
calv
cd
rva
ab
free
bovin
rvaspecif
asc
respons
mainli
isotyp
tissu
fig
case
galt
respons
asc
present
proxim
intestin
lamina
propria
duodenum
jejunum
lower
magnitud
pp
independ
treatment
fig
find
agreement
site
bovin
rva
infect
replic
small
intestin
repres
main
galt
effectorduodenum
jejunumand
inductiveileum
site
respect
asc
respons
indiana
rva
strain
duodenum
significantli
higher
igytr
group
control
group
igm
iga
isotyp
fig
trend
toward
higher
number
bovin
rva
asc
also
observ
tissu
includ
jejunum
lamina
propria
pp
asc
respons
mainli
associ
iga
isotyp
group
iga
abund
asc
indiana
rva
strain
pid
fig
igi
ab
chicken
egg
yolk
demonstr
effect
treatment
rvaassoci
diarrhea
experi
need
determin
igi
also
could
appli
commerci
product
studi
stabil
egg
yolk
powder
igi
ab
titer
indiana
rva
strain
elisa
sampl
kept
trilaminar
aluminum
packag
kept
differ
storag
condit
result
obtain
assay
depict
tabl
avian
igi
ab
react
indiana
rva
strain
year
powder
product
powder
kept
even
room
temperatur
stabil
condit
store
packag
sampl
high
temperatur
rh
rh
igi
ab
show
progress
loss
activ
time
tabl
day
month
powder
kept
rh
show
lower
elisa
igi
ab
titer
indiana
rva
strain
continu
decreas
day
powder
kept
rh
show
intermedi
stabil
loos
almost
igi
ab
biolog
activ
end
experi
day
tabl
physicochem
composit
microbiolog
statu
egg
yolk
powder
determin
packag
stage
day
powder
product
tabl
time
point
mention
regard
physicochem
composit
remain
quit
similar
last
checkpoint
day
powder
product
kept
even
room
temperatur
microbiolog
statu
accept
day
sampl
kept
room
temperatur
fig
geometr
mean
isotypespecif
neutral
ab
titer
gmt
indiana
rva
strain
serum
collect
weekli
line
calv
fed
colostrum
c
follow
bovin
rva
egg
yolk
supplement
milk
final
indiana
rva
igi
ab
titer
consecut
day
diarrhea
appear
b
calv
receiv
c
follow
nonsuppl
rva
ab
free
milk
c
colostrum
depriv
calv
receiv
rva
ab
free
milk
calv
oral
inocul
virul
indiana
rva
strain
pid
statist
analysi
ab
titer
serum
perform
anova
follow
dgc
multipl
comparison
test
time
p
b
indic
signific
differ
group
extend
day
sampl
storag
assay
conduct
determin
safeti
commerci
viabil
product
base
igi
ab
present
studi
evalu
use
igi
ab
bovin
rva
passiv
oral
therapeut
treatment
control
rvaassoci
diarrhea
newborn
calv
anim
experiment
inocul
bovin
indiana
rva
strain
genotyp
preval
rva
strain
circul
field
garaicoechea
et
al
badaracco
et
al
midgley
et
al
papp
et
al
control
group
colostrumdepriv
anim
calv
receiv
colostrum
treat
rvaspecif
passiv
treatment
includ
although
normal
newborn
calv
would
receiv
least
one
liter
colostrum
mother
mani
fail
stand
first
hour
life
nurs
soon
enough
gut
closur
calv
frequent
found
dairi
herd
argentina
surviv
compromis
lack
passiv
transfer
matern
immun
factor
antibodi
tripathi
vashishtha
osaka
et
al
result
obtain
demonstr
daili
oral
administr
egg
yolk
powder
enrich
igi
ab
bovin
rva
final
elisa
ab
titer
vn
titer
indiana
rva
strain
genotyp
significantli
reduc
number
day
diarrhea
hyperthermia
well
sever
ill
compar
colostrum
depriv
calv
receiv
virusspecif
treatment
regard
viru
shed
calv
treat
igi
ab
bovin
rva
clear
viru
infect
end
passiv
treatment
significantli
earlier
control
anim
receiv
colostrum
without
igi
ab
treatment
also
heterolog
igi
ab
colostrum
c
follow
bovin
rva
egg
yolk
supplement
milk
final
bovin
rva
igi
ab
titer
consecut
day
diarrhea
appear
calv
receiv
c
follow
nonsuppl
rva
ab
free
milk
colostrum
depriv
calv
receiv
rva
ab
free
milk
calv
oral
inocul
virul
indiana
rva
strain
pid
tissu
compar
mean
asc
number
isotyp
among
treatment
group
differ
letter
indic
signific
differ
kruskalw
rank
sum
test
p
b
n
number
calv
group
error
bar
indic
sd
indic
signific
differ
group
detect
elisa
fece
suggest
complet
degrad
intestin
tract
resist
igi
ab
calf
gut
environ
also
previous
observ
group
administr
fluid
crude
egg
yolk
passiv
prophylact
treatment
prevent
rvaassoci
diarrhea
newborn
calv
vega
et
al
fig
mean
number
bovin
rva
asc
per
mnc
obtain
galt
pid
calv
fed
colostrum
c
follow
milk
supplement
bovin
rva
egg
yolk
final
indiana
rva
igi
ab
titer
consecut
day
diarrhea
appear
calv
receiv
c
follow
nonsuppl
rva
ab
free
milk
colostrum
depriv
calv
receiv
rva
ab
free
milk
calv
oral
inocul
virul
bovin
rva
indiana
strain
pid
tissu
compar
mean
asc
number
isotyp
among
treatment
group
differ
letter
indic
signific
differ
kruskalw
rank
sum
test
p
b
n
number
calv
group
error
bar
indic
sd
indic
signific
differ
group
anoth
import
novel
featur
observ
studi
induct
stronger
rvaspecif
asc
respons
calv
receiv
milk
supplement
chicken
egg
yolk
powder
control
anim
receiv
colostrum
cd
calv
fed
rva
ab
free
milk
featur
previous
observ
calv
fed
milk
supplement
crude
egg
yolk
administ
prevent
strategi
longer
period
time
vega
et
al
result
togeth
demonstr
immunomodulatori
activ
local
affect
galt
asc
respons
current
experi
calv
fed
egg
yolk
powder
day
half
time
compar
previou
prophylact
experi
yet
modulatori
effect
egg
yolk
supplement
clearli
maintain
high
number
bovin
rvaspecif
asc
detect
galt
egg
yolk
treat
anim
repres
power
activ
immun
strategi
control
bovin
rva
diarrhea
well
potenti
enter
infect
result
agreement
presenc
immunomodulatori
molecul
egg
yolk
promot
b
cell
clonal
expans
iga
switch
relat
antiinflammatori
respons
dietari
antigen
nelson
et
al
previous
demonstr
immunomodulatori
effect
egg
yolk
relat
igi
ab
calv
treat
semipurifi
igi
ab
day
well
gnotobiot
pig
fed
milk
supplement
semipurifi
igi
ab
day
develop
statist
higher
asc
respons
galt
control
group
vega
et
al
howev
seem
like
igi
ab
treatment
caus
partial
suppress
activ
system
ab
respons
bovin
rva
could
associ
less
sever
diarrhea
treat
calv
system
ab
respons
bovin
rva
seem
higher
colostrum
depriv
calv
calv
show
intermedi
respons
report
igi
ab
bovin
rva
use
prevent
virusassoci
diarrhea
newborn
calv
vega
et
al
work
focu
treatment
clinic
sign
bovin
rva
infect
appear
mani
farmer
would
use
specif
treatment
prevent
one
also
shorten
passiv
treatment
day
compar
previou
prophylact
experi
group
vega
et
al
howev
even
day
twice
daili
continu
treatment
igi
ab
strong
versatil
immun
strategi
bovin
rvaassoci
diarrhea
anoth
import
featur
fact
passiv
treatment
administ
calv
experi
consist
mainli
egg
yolk
powder
easili
manipul
kept
room
temperatur
long
period
time
even
month
properti
emphas
advantag
egg
yolk
sourc
specif
antibodi
avian
ab
repres
reduct
refin
anim
use
karlsson
et
al
consid
ab
product
passiv
immunotherapi
applic
chicken
present
much
econom
sourc
larg
quantiti
specif
ab
also
less
invas
requir
daili
collect
egg
mine
kovacsnolan
karlsson
et
al
schade
et
al
kovacsnolan
mine
would
critic
develop
egg
yolk
powder
enrich
igi
ab
direct
sever
enteropathogen
involv
neonat
calf
diarrhea
repres
polyval
product
use
prevent
well
therapeut
strategi
control
calf
scour
dairi
farm
abbas
therapi
consist
polyclon
heterolog
ab
bovin
rva
passiv
oral
treatment
help
control
neonat
calf
diarrhea
importantli
approach
help
overcom
problem
microbi
resist
antibiot
use
indiscrimin
treat
calf
diarrhea
offer
innov
ecolog
power
solut
seriou
calf
health
problem
dairi
industri
